Cellebrite DI (CLBT) Total Non-Current Liabilities (2020 - 2026)

Cellebrite DI has reported Total Non-Current Liabilities for 7 years, with the latest figure at $92.0 million in Q2 2026.

• On a quarterly basis, Total Non-Current Liabilities rose 33.26% year-over-year to $92.0 million in Q2 2026; TTM through Jun 2026 was $92.0 million, a 33.26% increase from a year earlier, with the FY2025 full-year figure at $84.9 million, up 43.75% from the prior year.
• Total Non-Current Liabilities was $92.0 million for Q2 2026 at Cellebrite DI, up from $91.5 million in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $359.5 million in Q2 2024, with the low at $58.0 million in Q3 2024.
• Average Total Non-Current Liabilities over 5 years is $145.1 million, with a median of $112.5 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2025: Total Non-Current Liabilities soared 149.32% in 2022, then tumbled 81.76% in 2025.
• Over 5 years, Total Non-Current Liabilities stood at $121.7 million in 2022, then surged by 101.27% to $244.8 million in 2023, then tumbled by 75.89% to $59.0 million in 2024, then jumped by 43.75% to $84.9 million in 2025, then gained by 8.4% to $92.0 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $92.0 million (Q2 2026), $91.5 million (Q1 2026), and $84.9 million (Q4 2025), per Business Quant data.